Home » Topics » BioWorld

BioWorld
RSS

GENZYME GETS DIAGNOSTIC ENZYME BUSINESS

Nov. 5, 1991

PET CANCER TREATMENT CONDITIONALLY APPROVED

Nov. 5, 1991

IMMUNE TO FILE IND FOR ARTHRITIS VACCINE

Nov. 5, 1991

GENTA FILES 'QUIET' IPO

Nov. 5, 1991

BIOTECH BUBBLE MAY BE READY TO BURST

Nov. 5, 1991

SPHINX INKS FOUR-YEAR DEAL WITH LILLY

Nov. 5, 1991

SOMATIX GETS OPTIONS FOR CATHETER LICENSES

Nov. 5, 1991

IAMIN DECREASES WOUND HEALING TIME

Nov. 4, 1991

TSI ACQUIRES BRITISH TESTING SERVICE

Nov. 4, 1991

GENE THERAPY APPROACH TO IL-4

Nov. 4, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...